Loading clinical trials...

Study of the Carbon Dioxide Treatment for Fat Reduction | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITINGNA

Study of the Carbon Dioxide Treatment for Fat Reduction

A Pilot Study of the Carbon Dioxide Treatment for Fat Reduction

NCT00974415•Northwestern University

Summary

The primary objective of this study is to demonstrate the efficacy and safety of the carbon dioxide for subcutaneous fat reduction.

Eligibility

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Male or female subject ages ≥ 18 years old
•Body mass index (BMI) between 18.5-24.99. (BMI is defined as weight in pounds multiplied by 703 divided by the square of the height in inches).
•Subject in good health
•Willing and able to abstain from partaking in any treatment other than the study procedure (existing or new) to promote body contouring and/or weight loss during the course of study participation.
•Subject agrees to maintain their weight (i.e. within 5 pounds) by not making any changes to diet or lifestyle during the study.
•The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator

Exclusion Criteria

•Pregnant or lactating or intends to become pregnant in the next 9 months.
•Unable to understand the protocol or to give informed consent
•Any previous and/or pending procedures at the treatment area or that may likely affect the treatment area
•Pending and/or anticipated major change in diet or exercise pattern in the six weeks following the last treatment or who has taken diet pills within the last 6 months.
•History of asthma or chronic obstructive pulmonary diseases
•Active skin disease or skin infection in the treatment area
•Bleeding tendency or coagulopathy
•Subject who are allergic to lidocaine
•Any other condition that would, in the professional opinion of the investigator, potentially affect response or participation in the clinical study, or would pose as an unacceptable risk to the subject

Locations (1)

Northwestern University

Chicago, Illinois, United States

Key Dates

Start Date

January 1, 2010

Primary Completion Date

December 1, 2025

Completion Date

December 1, 2025

Last Updated

January 30, 2025

Enrollment

ESTIMATED participants

Conditions

Overweight

Interventions

CO2

PROCEDURE

Sham

PROCEDURE

Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women

NCT07472881

MenopausePerimenopause+2 more

View study

RECRUITINGNA

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss

NCT07237750

Overweight and/or ObesityMetabolic Syndrome+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 30, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study of the Carbon Dioxide Treatment for Fat Reduction

Inclusion Criteria

Exclusion Criteria

Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss

Effects of Cranberry on Gut and Metabolic Health

Personalizing Financial Incentives

High Phenolic Olive Oil for Enhancing Metabolic Health: a Randomized-controlled Trial in Patients With cEntral Obesity (HOPE)

Adherence to an Exercise Program and Pre- and Post-Changes After Bariatric Surgery